Pulmonary defense mechanisms against opportunistic fungal pathogens

A R Waldorf1

  • 1University of California, Berkeley.

Immunology Series
|January 1, 1989
PubMed

Insights

Host defenses against fungal infections like aspergillosis and mucormycosis involve distinct roles for alveolar macrophages and neutrophils. Macrophages kill Aspergillus conidia, while neutrophils damage fungal hyphae, highlighting varied nonimmune mechanisms against these opportunistic mycoses.

Area of Science:

  • Immunology
  • Mycology
  • Host-pathogen interactions

Background:

  • Nonimmune host defense mechanisms against aspergillosis and mucormycosis are not fully understood.
  • Prevention of these fungal infections relies on controlling spore germination and/or hyphal growth.
  • The host's immune system provides a barrier by controlling fungal spore germination, a critical step in infection.

Purpose of the Study:

  • To elucidate the distinct nonimmune host defense mechanisms against Aspergillus and Rhizopus.
  • To understand the roles of alveolar macrophages and neutrophils in combating these fungal infections.
  • To investigate the interplay of oxidative and nonoxidative mechanisms in limiting opportunistic mycoses.

Main Methods:

  • Comparative analysis of host pulmonary defenses against Aspergillus and Rhizopus.
  • Assessment of alveolar macrophage activity in conidia killing and spore germination inhibition.
  • Evaluation of neutrophil and macrophage/monocyte roles in damaging fungal hyphae.

Main Results:

  • Alveolar macrophages kill Aspergillus conidia but inhibit Rhizopus spore germination.
  • Neutrophils are crucial for damaging the hyphal forms of both Aspergillus and Rhizopus.
  • Host defenses vary, with macrophages and neutrophils acting distinctly against these fungi.

Conclusions:

  • Distinct nonimmune defense lines exist against Aspergillus and Rhizopus.
  • Alveolar macrophages and neutrophils play specialized roles in preventing and controlling invasive fungal infections.
  • Understanding these mechanisms is vital for combating opportunistic mycoses.

Related Concept Videos

Defense Mechanism Against Infection01:26

Defense Mechanism Against Infection

Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...